MedPath

Changes in quality of life through the early intervention by palliative care team for patients with advanced lung cancer

Phase 2
Conditions
lung cancer
Registration Number
JPRN-UMIN000012932
Lead Sponsor
Yokohama Municipal Citizen Hospital Department of Palliative Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1.There is a depression at the start of the test time is patient. 2. It is not possible for the patient to understand Japanese. 3.Patient is not able to visit once a month to our hospital. 4.If the attending physician was deemed inappropriate to participate in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoint is the difference between the QOL that was assessed by the EORTC QLQ c-15-PAL after 12 weeks after the start of the test and at the beginning of the study.
Secondary Outcome Measures
NameTimeMethod
Secondary endpoint is the change of each QOL item and an evaluation of QOL by the patients was compared with its estimation by the attending physicians.
© Copyright 2025. All Rights Reserved by MedPath